publication date: Dec. 19, 2010

In this issue: 

Congress signals willingness to break with administration on NIH funding.

Von Eschenbach says he will step down as NCI director; no acting director has been named.

ODAC finds increase in progression-free survival unconvincing to approve sNDA for Gemzar in advanced ovarian cancer.

Download (PDF 839KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.